See how AbbVie Inc. and Alphabet Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$254.49
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
Alphabet Inc. is a holding company that wholly owns Google, one of the world’s largest internet businesses. Based in California, the company generates just under 90% of its revenue from Google Services, with advertising sales representing the clear majority. In addition to digital advertising, Google Services includes revenue from subscription offerings such as YouTube TV and YouTube Music, platform sales and in-app purchases through the Play Store, and hardware products including Chromebooks, Pixel smartphones, and smart home devices like Chromecast. Google Cloud contributes about 10% of Alphabet’s total revenue. The remainder comes from investments in emerging technologies and businesses, including self-driving cars through Waymo, health initiatives via Verily, and internet access services such as Google Fiber.